BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8388030)

  • 21. [Condyloma acuminatum: detection of capsid antigen of human papillomavirus and microscopic study].
    Lin HL
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):231-4, 252. PubMed ID: 1655367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autogenous vaccine: the best therapy for perianal condyloma acuminata?
    Wiltz OH; Torregrosa M; Wiltz O
    Dis Colon Rectum; 1995 Aug; 38(8):838-41. PubMed ID: 7634978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A new method, based on in situ DNA hybridization, for the detection of papillomavirus in condyloma patients and their partners].
    Kiss M; Husz S; Soós J; Dobozy A
    Orv Hetil; 1993 Aug; 134(32):1739-42. PubMed ID: 8394562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas.
    Wikström A; Eklund C; von Krogh G; Lidbrink P; Dillner J
    APMIS; 1997 Nov; 105(11):884-8. PubMed ID: 9393560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of Human Papillomavirus Genotype in Anal Condyloma Acuminatum Among Japanese Men: The Higher Prevalence of High Risk Human Papillomavirus in Men Who Have Sex with Men with HIV Infection.
    Furukawa S; Uota S; Yamana T; Sahara R; Iihara K; Yokomaku Y; Iwatani Y; Sugiura W
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):375-381. PubMed ID: 29183133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and serological manifestations of genital human papillomavirus infection.
    Wikström A
    Acta Derm Venereol Suppl (Stockh); 1995; 193():1-85. PubMed ID: 8721519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus (HPV) in condylomatous lesions of cervix.
    Ferenczy A; Braun L; Shah KV
    Am J Surg Pathol; 1981 Oct; 5(7):661-70. PubMed ID: 6278970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of human papillomavirus 6/11 DNA in condyloma acuminatum of the urinary bladder.
    Iwasawa A; Kumamoto Y; Maruta H; Fukushima M; Tsukamoto T; Fujinaga K; Fujisawa Y; Kodama N
    Urol Int; 1992; 48(2):235-8. PubMed ID: 1316664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum.
    Arany I; Rady P; Tyring SK
    Am J Med Sci; 1995 Jul; 310(1):14-8. PubMed ID: 7541607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised double-blind trial of recombinant interferon-beta for condyloma acuminatum.
    Monsonego J; Cessot G; Ince SE; Galazka AR; Abdul-Ahad AK
    Genitourin Med; 1996 Apr; 72(2):111-4. PubMed ID: 8698357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
    Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of natural killer cell function during interferon-alpha treatment of patients with condyloma acuminatum is predictive of clinical response.
    Tyring SK; Cauda R; Ghanta V; Hiramoto R
    J Biol Regul Homeost Agents; 1988; 2(2):63-6. PubMed ID: 3188977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon resistance is independent from copy numbers in benign HPV-induced lesions.
    Arany I; Nagamani K; Tyring SK
    Anticancer Res; 1995; 15(3):1003-6. PubMed ID: 7645918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon.
    Liao MJ; Axelrod HR; Kuchler M; Yip YK; Kirkbright E; Testa D
    J Infect Dis; 1992 Apr; 165(4):757-60. PubMed ID: 1552208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of histology and human papillomavirus DNA detection in condyloma acuminatum and condyloma-like vulvar lesions.
    Nuovo GJ; O'Connell M; Blanco JS; Levine RU; Silverstein SJ
    Am J Surg Pathol; 1989 Aug; 13(8):700-6. PubMed ID: 2546460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical demonstration of papillomavirus antigen in cervical dysplasia and vulvar condyloma.
    Toki T; Oikawa N; Tase T; Satoh S; Wada Y; Yajima A
    Gynecol Obstet Invest; 1986; 22(2):97-101. PubMed ID: 3021598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups.
    Eisemann C; Fisher SG; Gross G; Müller M; Gissmann L
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1799-803. PubMed ID: 8760429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus infections of the genital tract.
    Brown DR; Fife KH
    Med Clin North Am; 1990 Nov; 74(6):1455-85. PubMed ID: 2174093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera.
    Suchánková A; Ritter O; Hirsch I; Krchnák V; Kalos Z; Hamsíková E; Brichácek B; Vonka V
    Acta Virol; 1990 Sep; 34(5):433-42. PubMed ID: 1705748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human papillomavirus seroconversions.
    Wikström A; van Doornum GJ; Quint WG; Schiller JT; Dillner J
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.